By Abigail Townsend
Date: Tuesday 23 Sep 2025
(Sharecast News) - Oxford Biomedica reiterated full-year guidance on Tuesday, after the biopharma saw strong demand throughout the first half and trimmed losses.
By Iain Gilbert
Date: Tuesday 26 Aug 2025
(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue guidance reiteration.
By Benjamin Chiou
Date: Friday 15 Aug 2025
(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.
Currency | UK Pounds |
Share Price | 615.00p |
Change Today | 19.00p |
% Change | 3.19 % |
52 Week High | 630.00p |
52 Week Low | 232.50p |
Volume | 225,031 |
Shares Issued | 120.21m |
Market Cap | £739.27m |
Beta | 0.00 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:47 | 3,678 @ 613.10p |
16:35 | 4 @ 615.00p |
16:35 | 1,026 @ 615.00p |
16:35 | 55,961 @ 615.00p |
16:35 | 276 @ 615.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research